1. Review of embryo-fetal developmental toxicity studies performed for recent FDA-approved pharmaceuticals;Ishihara-Hattori;Reprod. Toxicol.,2016
2. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2016 and 2017;Barrow;Reprod. Toxicol.,2018
3. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2018 and 2019;Barrow;Reprod. Toxicol.,2020
4. FDA, Pregnancy and Lactation Labeling Final Rule, 2014. 〈http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm〉. (Accessed March 10, 2022).
5. FDA, Oncology Pharmaceuticals: Reproductive Toxicity Testing and Labeling Recommendations. Guidance for Industry, 2019. 〈https://www.fda.gov/media/124829/download〉. (Accessed March 10, 2022).